EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders

Danielle Hj Kim, Lisa A Croen, Ana-Maria Iosif, Jennifer L Ames, Stacey Alexeeff, Yinge Qian, Robert H Yolken, Paul Ashwood, Judy Van de Water

Brain, Behavior, and Immunity · 2025

DOI: 10.1016/j.bbi.2024.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Danielle Hj Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA; Department of …. Hauptthemen laut MEDLINE: COVID-19, Neurodevelopmental Disorders, Pregnancy Complications, Infectious, SARS-CoV-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIMH NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the prevalence and significant concern of COVID-19 in maternal and offspring health, little is known about the impact of COVID-19 during pregnancy on newborn immunity and neurodevelopment. This study aimed to examine 1) the relationship between maternal COVID-19 during pregnancy and newborn immune profiles and investigate the 2) associations between specific newborn immune profiles and the risk of subsequent diagnosis of a neurodevelopmental disorder (NDD) among children with prenatal exposure to COVID-19. Newborn dried bloodspots (NBS) from 545 children born at Kaiser Permanente Northern California between January 2020 and September 2021 (460 [223 males, 237 females] to COVID-19-infected [COVID+] mothers; 85 [45 males, 40 females] to COVID-19-uninfected [COVID-] mothers) were used to profile newborn immune molecules via a 42-plex cytokine/chemokine assay. Among the 460 children born to COVID+ mothers, 73 (47 males, 27 females) were later diagnosed with an NDD. In the first set of analyses examining the association between maternal COVID-19 infection during pregnancy and newborn immune profile, the results adjusted for covariates but uncorrected for multiple comparisons showed that newborns of COVID+ mothers had significantly higher levels of IL-22 (estimate [est.] = 0.16, 95 % Cl 0.01, 0.3, p = 0.04) and GM-CSF (est. = 0.27, 95 % Cl 0.09, 0.46, p = 0.004) compared to newborns of COVID- mothers. These differences were no longer statistically significant after multiple comparison adjustments. In the second analysis exploring the association between newborn profile and later diagnosis of NDD among newborns born to COVID+ mothers, the results adjusted for covariates revealed an association between higher neonatal levels of IL-22 (hazard ratio [HR] = 0.49, 95 % Cl 0.33, 0.75, p = 0.001) and lower risk of a later diagnosis of an NDD, which remained significant after multiple comparison adjustments (p = 0.04). Other neonatal cytokines/chemokines/growth factors such as sCD40L (HR = 0.7, 95 % Cl 0.57, 0.9, p = 0.009), IP-10 (HR = 0.46, 95 % Cl 0.25, 0.83, p = 0.009), MIG (HR = 0.52, 95 % Cl 0.3, 0.9, p = 0.02), FLT-3L (HR = 0.45, 95 % Cl 0.24, 0.83, p = 0.01), PDGF AB/BB (HR = 0.56, 95 % Cl 0.36, 0.99, p = 0.046), VEGF (HR = 0.57, 95 % Cl 0.34, 0.98, p = 0.04), and IL-4 (HR = 0.48, 95 % Cl 0.26, 0.93, p = 0.03) were no longer statistically significant after multiple comparison adjustments. Despite the imbalance between the number of COVID-19 exposed and unexposed newborns in this study cohort, our novel findings enhance our understanding of the potential impact of maternal COVID-19 infection during pregnancy on the developing neonatal immune system. Our findings highlight the role of immune molecules, beyond those considered to be pro-inflammatory, that may be crucial in maternal and newborn immunity against COVID-19 infection during pregnancy. Furthermore, our results suggest that reduced levels of neonatal immune molecules in newborns of COVID + mothers may be linked to an increased risk of a subsequent diagnosis of an NDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Neurodevelopmental DisordersPregnancy Complications, InfectiousSARS-CoV-2Prenatal Exposure Delayed EffectsCytokinesHumansFemalePregnancyInfant, NewbornMaleAdultCalifornia

Stichwörter der Autor:innen

COVID-19 during pregnancyCytokineMaternal immune activation (MIA)Neurodevelopmental disorder (NDD)Newborn immunitySARS-CoV-2

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA; Department of Neurology and Neurological Sciences, Stanford University School of Med…
  • Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
  • Department of Public Health Sciences, Division of Biostatistics, University of California, Davis, CA, USA.
  • Stanley Division of Developmental Neurovirology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA; MIND Institute, University of California, Davis, CA, USA.
  • Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA; Department of Medical Microbiology and Immunology, University of California, Davis,…

Förderung

  • NICHD NIH HHS
  • NIMH NIH HHS
  • NIEHS NIH HHS
  • National Institute of Mental Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institutes of Health
  • National Institute of Child Health and Human Development

Zitieren

APA

Kim, D. H., Croen, L. A., Iosif, A. M., Ames, J. L., Alexeeff, S., Qian, Y., Yolken, R. H., Ashwood, P., & Van de Water, J. (2025). The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.11.014

Vancouver

Kim DH, Croen LA, Iosif AM, Ames JL, Alexeeff S, Qian Y, et al. The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2024.11.014

BibTeX
@article{Kim2025,
  author = {Kim, Danielle Hj and Croen, Lisa A and Iosif, Ana-Maria and Ames, Jennifer L and Alexeeff, Stacey and Qian, Yinge and Yolken, Robert H and Ashwood, Paul and Van de Water, Judy},
  title = {The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders},
  journal = {Brain, Behavior, and Immunity},
  year = {2025},
  doi = {10.1016/j.bbi.2024.11.014}
}
Kostenlos starten →